Literature DB >> 10217098

Hepatocellular carcinoma.

D F Schafer1, M F Sorrell.   

Abstract

Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable. Hepatitis B and C exist only in man; the viruses have no known non-human reservoirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection and improvements in medical techniques for hepatitis C, for which no vaccine has yet been developed.

Entities:  

Mesh:

Year:  1999        PMID: 10217098     DOI: 10.1016/S0140-6736(98)09148-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  112 in total

1.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients.

Authors:  G Q Gong; X L Wang; J H Wang; Z P Yan; J M Cheng; S Qian; Y Chen
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  No direct role for Epstein-Barr virus in American hepatocellular carcinoma.

Authors:  P G Chu; Y Y Chen; W Chen; L M Weiss
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  Localized Hepatocellular Carcinoma.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

5.  Integrin gene expression profiles of human hepatocellular carcinoma.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Zhi-Hua Liu; Jing Zhou; Wei-Hui Zhang; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

7.  Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.

Authors:  Xing Liu; Aileen Baecker; Ming Wu; Jin-Yi Zhou; Jie Yang; Ren-Qiang Han; Pei-Hua Wang; Zi-Yi Jin; Ai-Min Liu; Xiaoping Gu; Xiao-Feng Zhang; Xu-Shan Wang; Ming Su; Xu Hu; Zheng Sun; Gang Li; Alan Fu; Su Yon Jung; Lina Mu; Na He; Liming Li; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Liver Int       Date:  2019-07-10       Impact factor: 5.828

8.  EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

Authors:  Francesco Giammarile; Lisa Bodei; Carlo Chiesa; Glenn Flux; Flavio Forrer; Françoise Kraeber-Bodere; Boudewijn Brans; Bieke Lambert; Mark Konijnenberg; Françoise Borson-Chazot; Jan Tennvall; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07       Impact factor: 9.236

9.  LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?

Authors:  Seung Soo Kim; Jeong Ah Hwang; Hyeong Cheol Shin; Seo-Youn Choi; Tae Wook Kang; Sung Shick Jou; Woong Hee Lee; Suyeon Park; Nam Hun Heo
Journal:  Eur Radiol       Date:  2018-08-02       Impact factor: 5.315

10.  Risk factors for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Steedman A Sarbah; Terry Gramlich; Abraham Younoszai; Pat Osmack; Marlene Goormastic; Leonard Grosso; James N Cooper; Adrian Di Bisceglie; Russell Seneca; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.